Lawrence Erik Kurzius - 20 Aug 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: Director
Issuer ticker: ELAN
Reported as of: 20 Aug 2026
Net transaction value: +$935,920
SEC form: 4
Accepted by SEC: 21 Aug 2026, 16:16:46 UTC
Prior SEC filing: 12 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Lawrence Kurzius

Key filing fact

Lawrence Erik Kurzius filed Form 4 for Elanco Animal Health Inc (ELAN) on 21 Aug 2026.

Key facts

This page summarizes Lawrence Erik Kurzius's Form 4 filing for Elanco Animal Health Inc (ELAN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Aug 2026, 16:16.

Change

Previous filing in this sequence was filed on 12 Aug 2026.
Current net transaction value: +$935,920.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001352090 Primary reporting owner

Kurzius Lawrence Erik

Relationship: Director
Address: C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Lawrence Kurzius
Signature date: 21 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Common Stock

Purchase

Transaction value: $935,920
Shares: +40,000
Change %: +27%
Price: $23.40
Shares after: 188,647
Date: 20 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.